Elen has been taking capivasertib since her cancer returned and spread to her bones, stomach and bowel, after eight years of being cancer-free. NHS patients to be treated with new breast cancer drug A new targeted drug has been recommended for NHS patients in England and Wales for treating the most common type of advanced breast cancer. When used alongside another treatment type, the combination will treat over 1,000 patients a year, which could rise to over 3,000. Our scientists played a crucial role in the development of the drug, from years of research aimed at understanding how the AKT protein is regulated, to an early phase clinical trial. Our researchers are helping to improve the lives of many NHS patients living with advanced breast cancer. |